Document is current

Any future updates will be listed below

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

Crossref DOI link: https://doi.org/10.1007/s40120-022-00384-2

Published Online: 2022-07-13

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark